Align Technology Inc
$147.00
-$6.00 (-3.92%)
$146.82Day Range$152.49
Key Statistics
Market Cap
$10.87B
Shares Outstanding
71.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 26, 2001
Round Lot
100
Locale
US
Trading Data
Day Open
$151.46
Day High
$152.49
Day Low
$146.82
Volume
1.03M
VWAP
$148.06
Prev Close
$153.00
Transactions
--
Acc. Volume
--
About Align Technology Inc
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIESSIC 384220,435 employees410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, AZ, 85288408-470-1000IPO Jan 26, 2001US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001097149
- Composite FIGI
- BBG000BRNLL2
- Share Class FIGI
- BBG001SCF1B9
- Ticker Root
- ALGN
- SIC Code
- 3842
About Align Technology Inc (ALGN) Stock
Align Technology Inc (ALGN) closed the 2026-09-15 session at $147.00, down 3.92% versus the previous close (-6.00). The stock opened at $151.46 and traded between $146.82 and $152.49 during that session. Session trading volume was 1.0M shares. The volume-weighted average price (VWAP) is $148.06.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Align Technology Inc has a market capitalization of $10.87 billion. The company operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry classification. ALGN is listed on the XNAS exchange. The company employs approximately 20,435 people. Align Technology Inc is headquartered in TEMPE, AZ. The recorded listing date is 2001-01-26.
On this page you can find market ALGN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector.